Why the study?
Normal reference values for non-invasive myocardial mechano-energetic efficiency and indexed mechano-energetic efficiency were needed to evaluate LV cardiac mechanics.
What are the normal reference values for myocardial mechano-energetic efficiency (MEE) and indexed MEE (MEEi) in healthy subjects?
What are the normal reference values for myocardial mechano-energetic efficiency (MEE) and indexed MEE (MEEi) in healthy subjects?
This study establishes age- and gender-based normal reference values for myocardial mechano-energetic efficiency (MEE) and indexed MEE (MEEi) using transthoracic echocardiography in healthy subjects.
BACKGROUND: Myocardial mechano-energetic efficiency (MEE) is the capability of the left ventricle (LV) to convert the chemical energy obtained from the cardiac oxidative metabolism into mechanical work. The aim of present study was to establish normal non-invasive MEE and MEEi reference values. METHODS: In total, 1168 healthy subjects underwent physical examinations, clinical assessment, and standardized transthoracic echocardiographic (TTE) examination. MEE was obtained by TTE as the ratio between stroke volume (SV) and heart rate (HR): MEE = SV/HR [HR expressed in seconds (HR/60)]. Because MEE is highly related to left ventricular mass (LVM), MEE was then divided by LVM with the purpose of obtaining an estimate of energetic expenditure per unit of myocardial mass (i.e., indexed MEE, MEEi, mL/s/g). RESULTS: The mean values of MEE and MEEi in the overall population were 61.09 ± 18.19 mL/s; 0.45 ± 0.14, respectively. In a multivariable analysis, gender, body surface area (BSA), diastolic blood pressure, left atrial volume indexed to BSA, E/e' and tricuspid annular plane systolic excursion (TAPSE) were the independent variables associated with MEE, while age, gender, BSA and TAPSE were the independent variables associated with MEEi. CONCLUSIONS: The knowledge of age- and gender-based MEE and MEEi normal values may improve the global assessment of LV cardiac mechanics and serve as a reference to identify phenotypes at high risk of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Ferrara et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: